Robert Bruce's BBNX Position Overview
Robert Bruce (via Bruce & Co., Inc.) currently holds 550,700 shares of Beta Bionics, Inc. (BBNX) worth $5.52 M, representing 1.58% of the portfolio. First purchased in 2026-Q1, this recently established position has been held for 1 quarters.
Based on recent 13F filings, Robert Bruce has initiated a new position in BBNX, representing a fresh investment thesis on this company. Insufficient history to summarize additions or reductions.
Analysis based on 13F filings available since 2013 Q2
Robert Bruce's Beta Bionics (BBNX) Holding Value Over Time
Track share changes against reported price movement
Quarterly Beta Bionics (BBNX) Trades by Robert Bruce
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q1 2026 | +550,700 | New Buy | 550,700 | $10.02 |
Robert Bruce's Beta Bionics Investment FAQs
Robert Bruce first purchased Beta Bionics, Inc. (BBNX) in Q1 2026, acquiring 550,700 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Robert Bruce has held Beta Bionics, Inc. (BBNX) for 1 quarters since Q1 2026.
Robert Bruce's largest addition to Beta Bionics, Inc. (BBNX) was in Q1 2026, adding 550,700 shares worth $5.52 M.
According to the latest 13F filing for Q1 2026, Robert Bruce's firm, Bruce & Co., Inc., owns 550,700 shares of Beta Bionics, Inc. (BBNX), valued at approximately $5.52 M.
As of the Q1 2026 filing, Beta Bionics, Inc. (BBNX) represents approximately 1.58% of Robert Bruce's publicly disclosed stock portfolio, making it one of their key holdings.
Robert Bruce's peak holding in Beta Bionics, Inc. (BBNX) was 550,700 shares, as reported at the end of Q1 2026.